Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
|
Mid-range Performer
998.2000
-2.60
(
-0.26
%)
NSE
Jun 20, 2025
15:31 PM
25.23% Fall from 52W High
Volume:
57,987
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
16 Jul 2024
998.20
-0.26%
Glenmark Life Sciences Ltd
Buy:
Alivus Life Sciences Ltd.
by
Hem Securities
Target: 987 | Target met
Hem Securities
Alivus Life Sciences.. has an
average target
of 1152.00 from 2 brokers.
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - June 20, 2025
The Baseline |
20 Jun 2025, 07:03PM
Market closes higher, Hindustan Aeronautics bags an order worth Rs 500 crore from ISRO
Trendlyne Marketwatch |
20 Jun 2025, 03:59PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021